GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
For full access to this article login to GEN Select now.
Safety/Toxicity Issues in Drug Discovery
Companies Are Tasked With Quickly Finding Safe Compounds for Development
- As pressure increases on major pharma to bring new compounds into development, so too does pressure to make sure that these compounds are safe to test in humans. As evidenced in the TGN1214 trial last year, no company can afford to skip steps in insuring that the compounds tested ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.